Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice

OBJECTIVE: Oxyntomodulin (OXM) is a glucagon-like peptide 1 (GLP-1) receptor (GLP1R)/glucagon receptor (GCGR) dual agonist peptide that reduces body weight in obese subjects through increased energy expenditure and decreased energy intake. The metabolic effects of OXM have been attributed primarily...

Descripción completa

Detalles Bibliográficos
Autores principales: Pocai, Alessandro, Carrington, Paul E., Adams, Jennifer R., Wright, Michael, Eiermann, George, Zhu, Lan, Du, Xiaobing, Petrov, Aleksandr, Lassman, Michael E., Jiang, Guoqiang, Liu, Franklin, Miller, Corey, Tota, Laurie M., Zhou, Gaochao, Zhang, Xiaoping, Sountis, Michael M., Santoprete, Alessia, Capito', Elena, Chicchi, Gary G., Thornberry, Nancy, Bianchi, Elisabetta, Pessi, Antonello, Marsh, Donald J., SinhaRoy, Ranabir
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750209/
https://www.ncbi.nlm.nih.gov/pubmed/19602537
http://dx.doi.org/10.2337/db09-0278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750209/
https://www.ncbi.nlm.nih.gov/pubmed/19602537
http://dx.doi.org/10.2337/db09-0278

Ejemplares similares